43 GhouiliI.BahdoudiS.MorinF.AmriF.HamdiY.ColyP
AstraZeneca is eager to be included in this new trend, but is seeking some way to be ahead of the pack
This conversation helps us determine if semaglutide is appropriate for you and allows us to create a personalized treatment plan
2 Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario, Canada
As clinicians increasingly encounter patients with IBD as well as obesity, diabetes, or metabolic liver disease, there is a clear need to synthesize what is known about safety, metabolic effects, and IBD-specific outcomes to support evidence-informed clinical decision-making, explains senior investigator and study author Jolle St-Pierre, MD, PhD, FRCPC, a clinical assistant professor in the Division of Gastroenterology and Hepatology at the University of Calgary, Canada, in an email to Gastro Today